A partir de tradutores profissionais, empresas, páginas da web e repositórios de traduções disponíveis gratuitamente
kjer je ustrezno, je treba oceniti infektivnost in patogenost, razen če se lahko utemelji, da neciljni organizmi ne bodo izpostavljeni.
where applicable, an assessment of infectivity and pathogenicity is necessary, unless it can be justified that non-target organisms will not be exposed.
kolonizacija, infektivnost in toksičnost obsegajo zapleten sklop interakcij med mikroorganizmi in gostitelji, teh parametrov pa ni lahko razločevati kot neodvisne parametre;
colonisation, infectiveness and toxicity comprise a complex set of interactions between micro-organisms and hosts and these endpoints may not be resolved easily as independent endpoints;
Če enkratni odmerki ne dajo ustreznih rezultatov, je treba opraviti preskuse za določanje razpona, da bi ugotovili, ali obstajajo zelo toksična sredstva in kakšna je njihova infektivnost
in cases where a single dose is not appropriate, a set of range finding tests must be carried out to reveal highly toxic agents and infectivity
sposobnost za povzročitev (neškodljivih ali škodljivih) učinkov v gostitelju (kar kaže na infektivnost, patogenost in/ali toksičnost);
ability to produce non-adverse or adverse effects in a host, indicative of infectivity, pathogenicity, and/or toxicity;
v svojem mnenju z dne 28. aprila 2005 je efsa prišla do zaključka, da se na podlagi trenutnega znanstvenega znanja infektivnost, ki jo je moč ugotoviti, pojavi približno na 3/4 inkubacijske dobe.
in its opinion of 28 april 2005 the efsa concluded that on the basis of the current scientific knowledge likely detectable infectivity appears at about three quarters of the incubation period.
patogenost mikroorganizma za ljudi in (neciljne) živali, infektivnost mikroorganizma, sposobnost mikroorganizma za kolonizacijo, toksičnost metabolitov/toksinov in toksičnost ostankov rastnega gojišča, onesnaževalcev in pomožnih snovi v formulaciji so pomembni parametri pri ocenjevanju škodljivih učinkov, ki izhajajo iz fitofarmacevtskega sredstva;
the pathogenicity of the micro-organism to humans and non-target animals, the infectiveness of the micro-organism, the ability of the micro-organism to colonise, the toxicity of metabolites/toxins as well as the toxicity of the residual growth medium, contaminants and co-formulants, are important endpoints in assessing adverse effects arising from the plant protection product;